0000000000583299

AUTHOR

Pilar Rivera

showing 2 related works from this author

Protective Effects of Foam Rolling against Inflammation and Notexin Induced Muscle Damage in Rats

2019

It is known that high-intensity exercise can cause inflammation and damage in muscle tissue, and in recent years, physical therapists and fitness professionals have begun to use foam rolling as a recovery method to improve performance. Despite the lack of basic science studies to support or refute the efficacy of foam rolling, the technique is very widely used in the sports world. In this respect, we investigated whether foam rolling could attenuate muscle damage and inflammation. Female Wistar rats were assigned to control (C), foam rolling (FR), notexin without foam rolling (N) and notexin with foam rolling (NFR) groups. A 4.5 x 2 cm foam roller was used to massage their hind legs (two 60…

Muscle tissuemedicine.medical_specialtyN-group (finite group theory)InflammationHindlimbMuscle damage03 medical and health sciencesGrip strengthmuscle recovery0302 clinical medicinePhysical Conditioning AnimalInternal medicinefoam rollingmedicineAnimalsHumansMuscle StrengthRange of Motion ArticularRats WistarMuscle SkeletalPhysical Therapy ModalitiesBalance (ability)Elapid VenomsInflammationMassageTumor Necrosis Factor-alphaChemistryGeneral MedicineRatsPhysical TherapistsDisease Models Animalcell deathmedicine.anatomical_structureEndocrinology030211 gastroenterology & hepatologyFoam rollingmedicine.symptomperformanceInterleukin-1SportsResearch PaperInternational Journal of Medical Sciences
researchProduct

Glucocorticoid receptor antagonism overcomes resistance to BRAF inhibition in BRAF(V600E)-mutated metastatic melanoma

2019

Clinical applications of glucocorticoids (GC) in Oncology are dependent on their pro-apoptotic action to treat lymphoproliferative cancers, and to alleviate side effects induced by chemotherapy and/or radiotherapy. However, the mechanism(s) by which GC may also promote tumor progression remains unclear. GC receptor (GR) knockdown decreases the antioxidant protection of highly metastatic B16-F10 melanoma cells. We hypothesize that a GR antagonist (RU486, mifepristone) could increase the efficacy of BRAF-related therapy in BRAF(V600E)-mutated metastatic melanoma. In vivo formed spontaneous skin tumors were reinoculated into nude mice to expand the metastases of different human BRAF(V600E) mel…

Original ArticleMelanomaneoplasms
researchProduct